Unknown

Dataset Information

0

High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder.


ABSTRACT: BACKGROUND:Better indicators of prognosis are needed to personalise post-traumatic stress disorder (PTSD) treatments.AimsWe aimed to evaluate early symptom reduction as a predictor of better outcome and examine predictors of early response. METHOD:Patients with PTSD (N = 134) received sertraline or prolonged exposure in a randomised trial. Early response was defined as 20% PTSD symptom reduction by session two and good end-state functioning defined as non-clinical levels of PTSD, depression and anxiety. RESULTS:Early response rates were similar in prolonged exposure and sertraline (40 and 42%), but in sertraline only, early responders were four times more likely to achieve good end-state functioning at post-treatment (Number Needed to Treat = 1.8, 95% CI 1.28-3.00) and final follow-up (Number Needed to Treat = 3.1, 95% CI 1.68-16.71). Better outcome expectations of sertraline also predicted higher likelihood of early response. CONCLUSIONS:Higher expectancy of sertraline coupled with early response may produce a cascade-like effect for optimal conditions for long-term symptom reduction. Therefore, assessing expectations and providing clear treatment rationales may optimise sertraline effects. DECLARATION OF INTEREST:None.

SUBMITTER: Graham B 

PROVIDER: S-EPMC6263783 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder.

Graham Belinda B   Garcia Natalia M NM   Burton Mark S MS   Cooper Andrew A AA   Roy-Byrne Peter P PP   Mavissakalian Matig R MR   Feeny Norah C NC   Zoellner Lori A LA  

The British journal of psychiatry : the journal of mental science 20181025 6


<h4>Background</h4>Better indicators of prognosis are needed to personalise post-traumatic stress disorder (PTSD) treatments.AimsWe aimed to evaluate early symptom reduction as a predictor of better outcome and examine predictors of early response.<h4>Method</h4>Patients with PTSD (N = 134) received sertraline or prolonged exposure in a randomised trial. Early response was defined as 20% PTSD symptom reduction by session two and good end-state functioning defined as non-clinical levels of PTSD,  ...[more]

Similar Datasets

| S-EPMC6474244 | biostudies-literature
| S-EPMC5774817 | biostudies-literature
| S-EPMC5530272 | biostudies-other
| S-EPMC8670596 | biostudies-literature
| S-EPMC5499153 | biostudies-literature
| S-EPMC4168363 | biostudies-literature
| S-EPMC4416702 | biostudies-literature
| S-EPMC6082850 | biostudies-other
| S-EPMC4877688 | biostudies-other
| S-EPMC2791537 | biostudies-literature